Orgenesis Inc. (NASDAQ: ORGS) stock is down 8.32% despite the company reporting 400% increase in revenue to 9.4 million in Q1 2021.  Orgenesis increases revenue fourfold in Q1 2021 Vered Caplan the CEO of the company said that Q1 2021 results demonstrate the potential of the company’s new POCare strategy. […]